The invention provides methods and kits for rapid and inexpensive detection of hyposmia or anosmia, diminishment or loss of the sense of smell. Sudden onset of diminishment or loss of the sense of smell is an early sign of infection with SARS-CoV-2, the causative agent of COVID-19; detecting the sudden onset of diminishment or loss of the sense of smell can therefore be used to rapidly screen a population for persons who should undergo diagnostic testing for a SARS-CoV-2 infection, and more generally to screen persons for olfactory disorders.

The invention provides methods and kits for rapid and inexpensive detection of hyposmia or anosmia, diminishment or loss of the sense of smell. Sudden onset of diminishment or loss of the sense of smell is an early sign of infection with SARS-CoV-2, the causative agent of COVID-19; detecting the sudden onset of diminishment or loss of the sense of smell can therefore be used to rapidly screen a population for persons who should undergo diagnostic testing for a SARS-CoV-2 infection, and more generally to screen persons for olfactory disorders.

There is provided a vial cap with which, when there is a possibility that a cover which covers a stopper for a vial has come off and the stopper for the vial has been contaminated at a stage prior to use, the fact can easily be recognized. The vial cap is a resin vial cap (1) to be attached to a mouth portion (72) of a vial (70) to fix a stopper (74) fitted into the mouth portion (72) so that the stopper may not come off the mouth portion (72). The vial cap (1) is provided with a cap main body (8) that has an upper opening (6) formed therein and a cover (40) that covers the upper opening (6) of the cap main body (8). The cap main body (8) has a plurality of pin-receiving holes (10) formed therein, and the cover (40) has a plurality of fixing pins (46). Each pin-receiving hole (10) and a fixing pin (46) that is paired with the pin-receiving hole (10) are formed in complementary shapes. The plurality of fixing pins (46) of the cover (40) are accommodated in the plurality of pin-receiving holes (10) of the cap main body (8), and the cap main body (8) and the cover (40) are joined with the pin-receiving holes (10) and the fixing pins (46) engaged.

A borosilicate glass for a pharmaceutical container having high appearance quality, particularly a small number of air lines, and a glass tube for a pharmaceutical container are provided. The borosilicate glass for a pharmaceutical container contains, in mass %, from 70.0 to 78.0% of SiO.sub.2, from 5.0 to 8.0% of Al.sub.2O.sub.3, from 5.0 to 12.0% of B.sub.2O.sub.3, from 0 to 4.0% of CaO, from 0 to 4.0% of BaO, from 4.0 to 8.0% of Na.sub.2O, from 0 to 5.0% of K.sub.2O and from 0.001 to 1.0% of SnO.sub.2.

A glass for a pharmaceutical container of the present invention includes as a glass composition, in terms of mol %, 60% to 85% of SiO.sub.2, 3% to 20% of Al.sub.2O.sub.3, 0% to 5% of B.sub.2O.sub.3, 0% to 9% of Li.sub.2O, 0% to 12% of Na.sub.2O, 0% to 6% of K.sub.2O, 0.1% to 26% of Li.sub.2O+Na.sub.2O+K.sub.2O, 0% to 1% of SrO, and 0% to 1% of BaO, having a value for a molar ratio K.sub.2O/(Li.sub.2O+Na.sub.2O+K.sub.2O) of 0.60 or less, and having a value for a molar ratio Al.sub.2O.sub.3/(Li.sub.2O+Na.sub.2O+K.sub.2O) of 50 or less.

A glass for a pharmaceutical container of the present invention includes as a glass composition, in terms of mol %, 60% to 85% of SiO.sub.2, 3% to 20% of Al.sub.2O.sub.3, 0% to 5% of B.sub.2O.sub.3, 0% to 9% of Li.sub.2O, 0% to 12% of Na.sub.2O, 0% to 6% of K.sub.2O, 0.1% to 26% of Li.sub.2O+Na.sub.2O+K.sub.2O, 0% to 1% of SrO, and 0% to 1% of BaO, having a value for a molar ratio K.sub.2O/(Li.sub.2O+Na.sub.2O+K.sub.2O) of 0.60 or less, and having a value for a molar ratio Al.sub.2O.sub.3/(Li.sub.2O+Na.sub.2O+K.sub.2O) of 50 or less.

The present invention relates to a buffy coat extraction kit including: a kit body having a cylindrical plasma part that has an internal volume for forming a plasma layer, a cylindrical buffy coat part which extends in the longitudinal direction while communicating with the lower part of the plasma part and has a diameter smaller than the diameter of the plasma part and an internal volume for forming a buffy coat layer, and a cylindrical erythrocyte part which extends in the longitudinal direction while communicating with the lower part of the buffy coat part and has a diameter larger than the diameter of the buffy coat part and an internal volume for forming an erythrocyte layer, wherein the free end part of the plasma part and the free end part of the erythrocyte part are respectively opened; a lower packing movably accommodated in the erythrocyte part while maintaining an air-tight state; and a pusher moving the lower packing.

The present invention relates to a buffy coat extraction kit including: a kit body having a cylindrical plasma part that has an internal volume for forming a plasma layer, a cylindrical buffy coat part which extends in the longitudinal direction while communicating with the lower part of the plasma part and has a diameter smaller than the diameter of the plasma part and an internal volume for forming a buffy coat layer, and a cylindrical erythrocyte part which extends in the longitudinal direction while communicating with the lower part of the buffy coat part and has a diameter larger than the diameter of the buffy coat part and an internal volume for forming an erythrocyte layer, wherein the free end part of the plasma part and the free end part of the erythrocyte part are respectively opened; a lower packing movably accommodated in the erythrocyte part while maintaining an air-tight state; and a pusher moving the lower packing.

A method of providing a remedy is described. The method includes: (i) receiving, from a client device, answers to one or more of sets of questions that are relevant to one or more ailments and/or one or more unique expressions of the ailments; (ii) grading the answers using one or more remedy appropriateness values to produce graded answers, and wherein an remedy appropriateness value quantifies clinical importance of a remedy with respect to a question that is answered; (iii) scoring one or more remedies based on the graded answers to arrive at one or more remedy scores and identifying one or more top remedies that have high remedy scores; (iv) choosing, from a library of frequency files, one or more frequency files that correspond to one or more of the top remedies; and (v) presenting the frequency file as a remedy to the client device.

An object of the present invention is to automatically identify a direction, a posture and characteristics such as a shape, a size, a type and an expiration date of a medicine and store the medicine with ensuring a high degree of freedom. A medicine supplying apparatus 1 includes an identifying part and a storing part. A storing area is defined at the time of storing the medicine according to a size of a medicine contained in characteristics of the medicine identified by the identifying part. The medicine is stored in the storing part in a state that identification information of the medicine is associated with the storing area. Further, the medicine supplying apparatus has a determination processing part which can determine whether or not the medicine is a target to be treated based on the characteristics of the medicine identified by the identifying part.